1.Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636–645
2.Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001; 98:6917–6922
3.Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A: A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71:1296–1302
4.Munafo MR, Bowes L, Clark TG, Flint J: Lack of association of the COMT (Val158/108Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005; 10:765–770
5.Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Koeppe RA, Stohler CS, Goldman D: COMT Val158Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003; 299:1240–1243
6.Evans J, Xu K, Heron J, Enoch MA, Araya R, Lewis G, Timpson N, Davies S, Nutt D, Goldman D: Emotional symptoms in children: the effect of maternal depression, life events, and COMT genotype. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:209–218
7.Domschke K, Deckert J, O’Donovan MC, Glatt SJ: Meta-analysis of COMT Val158Met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 2007; 144:667–673
8.Pooley EC, Fineberg N, Harrison PJ: The Met158 allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol Psychiatry 2007; 12:556–561
9.Zhu G, Lipsky RH, Xu K, Ali S, Hyde T, Kleinman J, Akhtar LA, Mash DC, Goldman D: Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay. Psychopharmacology (Berl) 2004; 177:178–184
10.Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT: Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007; 27:10196–10209
11.Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I: Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994; 223:1049–1059
12.Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243–250
13.Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR: Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75:807–821
14.Ho BC, Wassink TH, O’Leary DS, Sheffield VC, Andreasen NC: Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005; 10:229:287–298
15.Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR: Catechol-O-methyltransferase Val158Met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003; 100:6186–6191
16.Goldman-Rakic PS: The cortical dopamine system: role in memory and cognition. Adv Pharmacol 1998; 42:707–711
17.Barnett JH, Scoriels L, Munafo MR: Meta-analysis of the cognitive effects of the catechol-O-methyl transferase gene Val158/108Met polymorphism. Biol Psychiatry 2008; 64:137–144
18.Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L: Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314:1930–1933
19.Chen X, Wang X, O’Neill AF, Walsh D, Kendler KS: Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 2004; 9:962–967
20.Chan RC, Chen RY, Chen EY, Hui TC, Cheung EF, Cheung HK, Sham P, Li T, Collier D: The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia. J Int Neuropsychol Soc 2005; 11:202–204
21.Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK: COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord 2007; 9:370–376
22.Diaz-Asper CM, Goldberg TE, Kolachana BS, Straub RE, Egan MF, Weinberger DR: Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol Psychiatry 2008; 63:72–79
23.Roussos P, Giakoumaki SG, Pavlakis S, Bitsios P: Planning, decision-making and the COMT rs4818 polymorphism in healthy males. Neuropsychologia 2008; 46:757–763
24.Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K, Jones PB: Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 2007; 164:142–149
25.Harrison PJ, Tunbridge EM: Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008; 33:3037–3045
26.Golding J, Pembrey M, Jones R: ALSPAC—the Avon Longitudinal Study of Parents and Children, I: study methodology. Paediatr Perinat Epidemiol 2001; 15:74–87
27.Wechsler D, Golombok S, Rust J: Wechsler Intelligence Scale for Children, 3rd ed. San Antonio, Tex, Psychological Corp, 1992
28.Manly T, Anderson V, Nimmo-Smith I, Turner A, Watson P, Robertson IH: The differential assessment of children’s attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry 2001; 42:1065–1081
29.Case R, Kurland DM, Goldberg J: Operational efficiency and the growth of short-term memory span. J Experimental Child Psychol 1982; 33:386–404
30.Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978–989
31.Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR: Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 2006; 11:867–877
32.Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, Okonofua F, Kajuna S, Karoma N, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu RB, Parnas J, Kidd JR, DeMille MM, Kidd KK: COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 2004; 9:859–870
33.Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 1998; 95:9991–9996
34.Xie T, Ho SL, Ramsden D: Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999; 56:31–38
35.Worda C, Sator MO, Schneeberger C, Jantschev T, Ferlitsch K, Huber JC: Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 2003; 18:262–266
36.Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR: Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999; 9:20–26
37.Williams GV, Goldman-Rakic PS: Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376:572–575
38.Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R, Weinberger DR, Berman KF: Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 2005; 8:594–596
39.Shifman S, Bhomra A, Smiley S, Wray NR, James MR, Martin NG, Hettema JM, An SS, Neale MC, van den Oord EJ, Kendler KS, Chen X, Boomsma DI, Middeldorp CM, Hottenga JJ, Slagboom PE, Flint J: A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry 2008; 13:302–312
40.Bilder RM, Volavka J, Lachman HM, Grace AA: The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004; 29:1943–1961
41.Tunbridge EM, Lane TA, Harrison PJ: Expression of multiple catechol-o-methyltransferase (COMT) mRNA variants in human brain. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:834–839
42.Tunbridge EM, Weickert CS, Kleinman JE, Herman MM, Chen J, Kolachana BS, Harrison PJ, Weinberger DR: Catechol-O-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex 2007; 17:1206–1212
43.Gimelbrant A, Hutchinson JN, Thompson BR, Chess A: Widespread monoallelic expression on human autosomes. Science 2007; 318:1136–1140